{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Realizing the Promise of Immunotherapy in the Clinic

Activity Steps

1 Activity
2 Take Test 3Certificate

Purpose of Activity

To provide information on the development of targeted immunotherapy.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify challenges to the development of targeted immunotherapies.
  2. Discuss various types of cancer immunotherapies and results of studies using these treatments.

Disclosures

All authors, staff, and planners, including spouses/partners (if any), in any position to control the content of this CME activity have disclosed that they have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity.

Price: $17.95

Credits:

  • ANCC 1.5 CH
  • DC - BON 1.5 CH
  • KY-BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, #50-1223, Florida Board of Nursing, #50-1223, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.







Planner
Test Code: OT0516
Published: May 2016
Expires: 12/31/2026
Sources: Oncology Times
Required Passing Score: 7/10 (70%)
Authors: Peggy Eastman
Categories: Cancer , Oncology
Specialties: Oncology
Topics: Cancer , Immunotherapy